Federated Hermes’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $283K | Sell |
966
-225
| -19% | -$73.9K | ﹤0.01% | 1434 |
|
|
2025
Q4 | $418K | Sell |
1,191
-50
| -4% | -$16.9K | ﹤0.01% | 1359 |
|
|
2025
Q3 | $401K | Sell |
1,241
-25,361
| -95% | -$7.89M | ﹤0.01% | 1390 |
|
|
2025
Q2 | $10.3M | Sell |
26,602
-1,872
| -7% | -$753K | 0.02% | 565 |
|
|
2025
Q1 | $12.4M | Sell |
28,474
-3,060
| -10% | -$1.23M | 0.03% | 511 |
|
|
2024
Q4 | $11.6M | Sell |
31,534
-18,901
| -37% | -$7.91M | 0.03% | 521 |
|
|
2024
Q3 | $26.2M | Buy |
50,435
+1,268
| +3% | +$677K | 0.06% | 365 |
|
|
2024
Q2 | $26.6M | Buy |
49,167
+861
| +2% | +$455K | 0.06% | 333 |
|
|
2024
Q1 | $25M | Buy |
48,306
+5,644
| +13% | +$2.81M | 0.06% | 368 |
|
|
2023
Q4 | $20.1M | Buy |
42,662
+1,128
| +3% | +$522K | 0.05% | 381 |
|
|
2023
Q3 | $18.1M | Sell |
41,534
-1,327
| -3% | -$602K | 0.05% | 391 |
|
|
2023
Q2 | $19M | Buy |
42,861
+14,195
| +50% | +$6.55M | 0.05% | 407 |
|
|
2023
Q1 | $13.2M | Buy |
28,666
+1,169
| +4% | +$556K | 0.03% | 484 |
|
|
2022
Q4 | $14.1M | Buy |
27,497
+10,569
| +62% | +$5.37M | 0.04% | 459 |
|
|
2022
Q3 | $7.69M | Buy |
16,928
+1,927
| +13% | +$922K | 0.02% | 590 |
|
|
2022
Q2 | $7.24M | Buy |
15,001
+10,791
| +256% | +$5.34M | 0.02% | 621 |
|
|
2022
Q1 | $2.07M | Sell |
4,210
-22,018
| -84% | -$10.1M | ﹤0.01% | 1028 |
|
|
2021
Q4 | $12.2M | Sell |
26,228
-14,434
| -35% | -$6.07M | 0.02% | 595 |
|
|
2021
Q3 | $15.2M | Buy |
40,662
+1,912
| +5% | +$727K | 0.03% | 541 |
|
|
2021
Q2 | $14.8M | Buy |
38,750
+6,485
| +20% | +$2.48M | 0.03% | 554 |
|
|
2021
Q1 | $11.6M | Buy |
32,265
+2,746
| +9% | +$883K | 0.02% | 624 |
|
|
2020
Q4 | $9.48M | Buy |
29,519
+12,191
| +70% | +$3.74M | 0.02% | 653 |
|
|
2020
Q3 | $4.65M | Buy |
17,328
+4,931
| +40% | +$1.33M | 0.01% | 744 |
|
|
2020
Q2 | $3.26M | Buy |
12,397
+2,378
| +24% | +$634K | 0.01% | 832 |
|
|
2020
Q1 | $2.27M | Sell |
10,019
-62,932
| -86% | -$17.2M | 0.01% | 853 |
|
|
2019
Q4 | $22M | Sell |
72,951
-113,801
| -61% | -$31.3M | 0.05% | 390 |
|
|
2019
Q3 | $44.8M | Sell |
186,752
-41,250
| -18% | -$11.3M | 0.11% | 212 |
|
|
2019
Q2 | $64.3M | Buy |
228,002
+2,379
| +1% | +$650K | 0.16% | 148 |
|
|
2019
Q1 | $64.7M | Buy |
225,623
+91,361
| +68% | +$26.4M | 0.16% | 136 |
|
|
2018
Q4 | $35.3M | Buy |
134,262
+40,488
| +43% | +$11.1M | 0.1% | 226 |
|
|
2018
Q3 | $25.7M | Sell |
93,774
-64,862
| -41% | -$16.8M | 0.06% | 297 |
|
|
2018
Q2 | $37.8M | Buy |
158,636
+46,696
| +42% | +$10.8M | 0.11% | 162 |
|
|
2018
Q1 | $24.6M | Buy |
111,940
+7,557
| +7% | +$1.78M | 0.07% | 213 |
|
|
2017
Q4 | $23.5M | Buy |
104,383
+13,200
| +14% | +$2.81M | 0.07% | 224 |
|
|
2017
Q3 | $17.3M | Sell |
91,183
-3,245
| -3% | -$618K | 0.05% | 285 |
|
|
2017
Q2 | $17.8M | Sell |
94,428
-52,209
| -36% | -$9.38M | 0.05% | 288 |
|
|
2017
Q1 | $24.3M | Sell |
146,637
-123,478
| -46% | -$19.6M | 0.07% | 237 |
|
|
2016
Q4 | $38.8M | Sell |
270,115
-132,133
| -33% | -$17.7M | 0.12% | 152 |
|
|
2016
Q3 | $50.4M | Buy |
402,248
+78,524
| +24% | +$10.1M | 0.15% | 118 |
|
|
2016
Q2 | $42.5M | Buy |
323,724
+31,829
| +11% | +$4.36M | 0.12% | 136 |
|
|
2016
Q1 | $40.6M | Buy |
291,895
+48,358
| +20% | +$6.46M | 0.13% | 145 |
|
|
2015
Q4 | $34M | Buy |
243,537
+129,507
| +114% | +$17.8M | 0.11% | 178 |
|
|
2015
Q3 | $16M | Sell |
114,030
-146,736
| -56% | -$22.1M | 0.05% | 327 |
|
|
2015
Q2 | $42.8M | Buy |
260,766
+33,675
| +15% | +$5.38M | 0.13% | 169 |
|
|
2015
Q1 | $35.1M | Buy |
227,091
+3,067
| +1% | +$437K | 0.11% | 185 |
|
|
2014
Q4 | $28.2M | Buy |
224,024
+31,895
| +17% | +$3.94M | 0.09% | 222 |
|
|
2014
Q3 | $23M | Sell |
192,129
-2,860
| -1% | -$328K | 0.07% | 265 |
|
|
2014
Q2 | $21M | Buy |
194,989
+8,179
| +4% | +$843K | 0.07% | 293 |
|
|
2014
Q1 | $18.6M | Buy |
186,810
+26,817
| +17% | +$2.43M | 0.06% | 293 |
|
|
2013
Q4 | $14.8M | Sell |
159,993
-142
| -0.1% | -$12.6K | 0.05% | 334 |
|
|
2013
Q3 | $13.4M | Buy |
160,135
+2,213
| +1% | +$190K | 0.05% | 306 |
|
|
2013
Q2 | $12.9M | Buy |
+157,922
| New | +$11.8M | 0.05% | 286 |
|
Other funds holding ELV
VCM
VPM
Federated Hermes's ELV Position: Q1 2026 in Review
Federated Hermes reduced its Elevance Health (ELV) stake by 19% in Q1 2026, selling an estimated $73.9K and leaving 966 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #1434.
Federated Hermes first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $64.7M in Q1 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Federated Hermes held 966 shares of Elevance Health worth $283K as of Q1 2026.
- Federated Hermes sold 225 Elevance Health shares in Q1 2026, an estimated $73.9K.
- Elevance Health made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1434 holding.
- Federated Hermes first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Federated Hermes's Elevance Health position peaked at $64.7M in Q1 2019.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.